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Serum IL-8 in Patients with Dermatitis Herpetiformis
is Produced in Response to Dietary Gluten
Russell P. Hall III1, Keith M. Benbenisty1, Clinzo Mickle1, Fumiko Takeuchi1 and Robert D Streilein1
Patients with dermatitis herpetiformis (DH) have a gluten-sensitive enteropathy and while on gluten-containing
diets have elevated levels of serum IL-8. We hypothesized that the mucosal immune response to gluten is
responsible for the elevated serum IL-8. Six DH patients were studied while on a gluten-free diet (GFD), whereas
four continued on a normal diet. Patients were followed for a mean 2.2 years and serum IL-8 was analyzed. Small
bowel biopsies from five DH patients on normal diets, two DH patients on GFD, and six subjects with no small
bowel abnormalities were analyzed for IL-8 mRNA. Serum IL-8 levels normalized in five of six patients on GFD
and decreased in one, whereas serum IL-8 levels showed no statistically significant change in DH patients on
normal diets. Small bowel biopsies from DH patients on normal diets had increased expression of IL-8 mRNA
compared to normal subjects, whereas patients on a GFD showed no significant increase in small bowel mRNA.
No significant IL-8 mRNA was detected in normal skin biopsies from patients with DH. These observations
suggest that the IL-8 in the serum of patients with DH originates from the small bowel as a mucosal immune
response to gluten ingestion.
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INTRODUCTION
The skin lesions of dermatitis herpetiformis (DH) are
characterized by the presence of a predominantly neutro-
philic infiltrate at the dermal epidermal junction and
presence of cutaneous IgA deposits at the dermal–epidermal
junction (Hall, 1992; Fry, 1997). The predominant neutro-
philic nature of the infiltrate in the lesional skin of patients
with DH suggests an inflammatory process that is predis-
posed to the relatively specific activation of neutrophils.
Although the exact mechanisms involved in the formation of
the skin lesions are not known, it is clear that the associated
gluten-sensitive enteropathy (GSE) that is present in patients
with DH plays a critical role. Patients with DH can control
their skin lesions by adherence to a gluten-free diet (GFD)
and in many instances can totally discontinue the use of
dapsone as a means of controlling their skin disease (Fry
et al., 1968; Reunala et al., 1977, 1978).
We have previously demonstrated that neutrophils from
DH patients with ongoing skin lesions show increased
expression of CD11b, a slight decreased expression of
L-selectin and increased function of the FcIgA receptor, all
suggesting partial priming of the neutrophils (Smith et al.,
2002). IL-8 (CXCL8) is a chemokine that is a potent neutrophil
chemoattractant and mediates neutrophil function in part
through increasing expression of neutrophil cell surface
CD11b and inducing shedding of L-selectin, similar to what
we have observed to be present in patients with DH (Detmers
et al., 1990; Hoch et al., 1996; Mukaida et al., 1998). We
have previously shown that patients with DH have increased
levels of serum IL-8 (Hall et al., 2006). The source of the
increased serum IL-8 found in patients with DH is not known.
IL-8 is produced in skin after minor trauma or UVB
(Strickland et al., 1997; Takeuchi et al., 2003). Although
elevated levels of serum IL-8 are seen in patients with active
skin disease, IL-8 is also elevated in patients who are on
gluten-containing diets but have no active skin lesions owing
to therapy with dapsone. These observations suggest that the
gastrointestinal mucosa, and not inflamed epidermis, may be
the source of the elevated serum IL-8. We hypothesized that
the elevated serum IL-8 in patients with DH arises in the gut
as a result of the immune response to dietary gluten. To test
this hypothesis, we examined serum IL-8 levels in patients
with isolated GSE on gluten-containing diets, serum IL-8
levels in patients with DH before and after adherence to a
GFD and IL-8 mRNA levels in the gut of patients with DH on
normal and GFDs. In addition, we examined IL-8 mRNA
levels in normal and lesional skin of patients with DH.
RESULTS
Serum IL-8 and IgA anti-tissue transglutaminase return to
normal on GFD
IL-8 levels were elevated in seven of 10 patients with DH
before beginning a GFD (mean IL-8¼ 203.4 pg/ml; range¼
3.15–1639 pg/ml; normalo4.91 pg/ml). IgA anti-tissue
transglutaminase levels (TTG) were elevated in all
DH patients studied (IgA anti-TTG mean¼169.75 U/ml;
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range¼ 16.69–787.4 U/ml; normalo10 U/ml). No statistically
significant differences in the IL-8 levels were noted between
patients that began a GFD compared to those who remained on
a gluten-containing diet (P¼0.61, Mann–Whitney test). Patients
who began a GFD did have a significantly lower initial
IgA anti-TTG level (mean pre-GFD¼ 62.2 U/ml; mean con-
tinue normal diet¼331.1 U/ml; P¼ .0190; Mann–Whitney
test), although values for all patients were outside the normal
range. No elevation of other cytokines was noted compared
to normal subjects, including IL-1b, IL-2, IL-4, IL-5, IL-6, IL-
10, IL-12p70, IL-13, IL-17, GM-CSF, G-CSF, TNF-a, INF-g,
MIP-1b, or MCP-1 (data not shown).
Six of 10 patients with DH elected to begin (five patients)
or continue (one patient) a GFD and serum samples were
analyzed again after maintaining a GFD for 24.5 months
(range¼ 0.5–40 months). Five of the six patients were already
on dapsone or sulfapyridine before institution of the diet and
one patient began the diet at the time of diagnosis. Serum IL-8
decreased in all patients on GFD (Figure 1) (P¼0.0156,
Wilcoxon Signed Ranks test). Initial IgA TTG was elevated in
all subjects that began a GFD (16.7–175 U/ml; normalo10),
returned to normal in five of six patients on a GFD and
decreased in 1 GFD patient (176–15 U/ml) (P¼0.0156,
Wilcoxon Signed Ranks test) (Table S1).
In contrast to patients on a GFD, patients that maintained
a regular, gluten-containing diet during the study had serum
IL-8 levels that were not statistically significantly different
between initial and subsequent samples (Figure 2) (P¼0.438,
Wilcoxon Signed Ranks test). IgA TTG likewise remained
elevated in all patients on a normal diet with no statistically
significant change (P¼0.437, Wilcoxon Signed Ranks test)
(Table S1).
Increased IL-8 mRNA in small bowel of patients with DH on
normal diet
Small bowel biopsies obtained from seven patients with DH
were analyzed for IL-8 mRNA expression. Five of the seven
DH patients were on a gluten-containing diet, whereas two
patients with DH were on GFD. Routine histology of the
small bowel biopsies showed moderate to severe villous
atrophy and inflammation in all patients on a regular diet and
normal morphology in one patient on a GFD and mild villous
atrophy in the second patient on a GFD. IL-8 mRNA levels
were normalized to 18S mRNA expression in all patients and
normal subjects. Patients with DH on a regular diet had a
significantly increased level of IL-8 mRNA when compared
with normal subjects (DH Patients on Gluten diet: mean IL-8
mRNA expression¼26.51 arbitrary unit (AU); range¼
7.0–88.1; normal Subjects: mean IL-8 mRNA expres-
sion¼2.80; range¼ 0.51–5.69) (P¼ 0.0022, Mann–Whitney
Test) (Figure 3). In contrast, the IL-8 mRNA expression in the
small bowel biopsies from patients with DH on a GFD were
not significantly different from that seen in normal subjects
(DH patients on GFD: mean IL-8 mRNA expression¼
3.69 AU; range¼1.64–5.74) (P¼ 0.857, Mann–Whitney
test).
Serum IL-8 and IgA anti-tissue transglutaminase levels in
patients with isolated GSE on gluten-containing diets
IL-8 levels were elevated in 10 of 11 patients with isolated
GSE that were on a gluten-containing diet (mean IL-
8¼3,352 pg/ml; range¼0–12,000 pg/ml; normal o4.91 pg/
ml). IgA anti-tissue transglutaminase levels were elevated in
eight of 11 patients with isolated GSE (mean IgA anti-
TTG¼ 79.44; range: 3.19–174.9 U/ml; normalo10 U/ml)
(Table S2).
IL-8 mRNA in normal and lesional skin of patients with DH
Skin biopsies from six patients with DH and eight normal
subjects were obtained and analyzed for IL-8 mRNA
expression. Skin biopsies from patients with DH were
obtained from normal inner arm skin during a time of no
disease activity on dapsone, from normal inner arm skin off of
dapsone during disease activity and from an active blister of
the same patient. No IL-8 mRNA was detectable from the
normal inner arm skin of patients with DH on dapsone,
whereas minimal levels were detected in the normal subject
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Figure 1. Serum IL-8 levels in patients with DH on regular and GFDs. Serum
IL-8 is significantly reduced in patients with DH after maintaining a GFD
(open bars) when compared to levels, while on a gluten containing normal
diet (solid bars) (P¼ 0.0156, Wilcoxon Signed Ranks Test).
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Figure 2. Serum IL-8 levels in patients with DH on regular diet. Serum IL-8 is
not significantly different in patients with DH over time, while on a gluten
containing, normal, diet (solid bars) (P¼ 0.437, Wilcoxon Signed Ranks Test).
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inner arm skin (normal mean: 3.27 IL-8 mRNA/18S mRNA
AU) (Table 1). Five of six normal appearing inner arm skin
biopsies obtained at the time of biopsy of lesional skin also
had no detectable IL-8 mRNA, whereas one normal appear-
ing skin biopsy had elevated IL-8 mRNA levels. In contrast,
lesional skin IL-8 mRNA expression was elevated in six of six
lesional skin biopsies to a level greater than seen in normal
DH skin or in DH gut biopsies (IL-8 mRNA/18S mRNA AU:
DH lesional skin mean: 432.17; small bowel on gluten:
26.51) (Table 1).
DISCUSSION
The skin lesions found in patients with DH are characterized
by the accumulation of neutrophils at the dermal–epidermal
junction (Katz, 1980; Blenkinsopp et al., 1983). Although
these skin lesions can be controlled by the use of dapsone,
the clinical manifestations of DH can also be managed by
adherence to a GFD (Fry et al., 1968; Reunala et al., 1984).
Despite this well-documented clinical association, the
mechanisms through which gastrointestinal sensitivity to
gluten results in the development of the characteristic skin
lesions of DH are not known. IL-8 is a chemokine that plays
an important role in neutrophil inflammatory responses
including upregulation of neutrophil expression of CD11b
and shedding of L-selectin, steps necessary for firm adhesion
to endothelial cells and movement into tissue (Hoch et al.,
1996; Mukaida et al., 1998). In addition, IL-8 is expressed in
tissue with neutrophilic infiltrates and injection of IL-8 into
skin results in the accumulation of neutrophils (Lira et al.,
1994; Douglass et al., 1996; Murphy, 1997). We previously
demonstrated that neutrophils in patients with DH have
elevated expression of CD11b, a decreased expression of
L-selectin and increased function of neutrophil Fc IgA receptor
(Smith et al., 2002). These findings are consistent with those
induced on neutrophils after exposure to IL-8 (Mukaida et al.,
1998). We have also previously shown that patients with DH
have elevated serum levels of IL-8 (Smith et al., 2002; Hall
et al., 2006). Owing to the association of DH with a GSE, as
well as the control of the skin lesions of DH by a strict GFD,
we hypothesized that the inflammatory response in the small
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Figure 3. Expression of IL-8 mRNA in small bowel of patients with DH on gluten-free and regular, gluten-containing diets. Expression of IL-8 mRNA is
increased in the small bowel mucosa of patients with DH on a regular gluten-containing diet compared to normal subjects on a regular diet (P¼ 0.0022,
Mann–Whitney Test). Patients with DH on GFDs show no difference in IL-8 mRNA expression compared to normal subjects (P¼0.857, Mann–Whitney Test).
Table 1. IL-8 mRNA expression in normal and lesional
skin of patients with dermatitis herpetiformis and
normal subjects
Subject1
Normal skin on
dapsone IL-8
mRNA2
Normal skin off
dapsone IL-8
mRNA
Lesional skin
IL-8 mRNA
15 03 0 1667.5
16 0 473.25 255.2
8 0 0 2.06
6 0 0 459.48
17 0 0 129.82
10 0 0 78.96
Normal 1 0.15 Not done Not done
Normal 2 21.0 Not done Not done
Normal 3 0 Not done Not done
Normal 4 0.41 Not done Not done
Normal 5 0.49 Not done Not done
Normal 6 0.29 Not done Not done
Normal 7 0.13 Not done Not done
Normal 8 0.42 Not done Not done
AU, arbitrary unit; DH, dermatitis herpetiformis.
1Subject DH patients, numbers refer to DH demographic Tables S1 and
S2.
2Normal inner arm skin obtained while on dapsone.
3IL-8 mRNA normalized to 18S RNA, AU. 0 means no detectable IL-8
mRNA detectable.
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bowel secondary to dietary ingestion of gluten may be the
source of the elevated serum IL-8 in patients with DH.
We have found that in six patients with DH, adherence to
a GFD resulted in a decrease in serum IL-8 levels and
normalization of IgA anti-TTG antibodies, whereas in patients
on a normal diet, IL-8 and IgA anti-TTG levels showed no
statistically significant change. In addition, small bowel
biopsies from DH patients on GFDs showed expression of
IL-8 mRNA similar to that seen in small bowel biopsies from
normal subjects. Small bowel biopsies from DH patients on
gluten-containing diets, however, showed significantly ele-
vated expression of IL-8 mRNA. As IL-8 can be produced by a
wide variety of cells including keratinocytes and fibroblasts,
we also evaluated the expression of IL-8 mRNA in the normal
skin of patients with DH and found no significant IL-8 mRNA
expression. These observations suggest that gluten ingestion
leads to increased serum IL-8, the small bowel may be the
source of this IL-8, and a GFD leads to a reversal of this
abnormality.
To determine if the elevation of serum IL-8 is specific for
DH, we also studied patients with isolated GSE on gluten-
containing diets. Serum IL-8 levels were also elevated in
these patients. Although these patients were not able to be
studied while on a GFD, these findings add further support to
the concept that the increase in serum IL-8 in patients with
DH and isolated GSE is related to the gut mucosal immune
response.
The ability of gliadin to stimulate production of IL-8 has
been demonstrated both in vitro and in vivo previously.
Chowers et al. (1997) reported that local gluten challenge to
the rectal mucosa of patients with isolated GSE resulted in a
significant increase in IL-8 mRNA within 2 hours of the
challenge that persisted for 12 hours after the challenge.
Similar studies have demonstrated that gluten challenge in
the rectum of patients with isolated GSE also demonstrate an
increased expression of E-selectin and vascular cell adhesion
molecule-1 on mucosal vasculature (Ensari et al., 1993). In
vitro studies by Jelinkova et al. (2004) have also demonstrated
that human monocyte cell lines stimulated with gliadin
produced IL-8. In addition, cultured microvascular endothe-
lial cells from human jejunal mucosa have been shown to
produce IL-8 in response to supernatants from gluten-reactive
T-cell lines derived from patients with isolated GSE (Nilsen
et al., 1998). These findings all support our findings that IL-8
in the serum of patients with DH and those with isolated GSE
appears to arise from a mucosal immune response to a
gluten-containing diet, however, the exact cellular origin of
the IL-8 in the gastrointestinal mucosa cannot be established.
The role of IL-8 in the pathogenesis of the gut disease in
patients with gluten sensitivity is not clear. IL-8 is a potent
neutrophil chemokine, however, neutrophils are not promi-
nently noted in the small bowel biopsies of patients with
isolated GSE or in the GSE associated with DH. It is of interest
that in time course studies carried out after gluten challenges
in the rectum of patients with isolated GSE, neutrophils were
most prominently present in the first 4–6 hours (Loft et al.,
1989; Kristjansson et al., 2005). This finding suggests that
neutrophils may represent an early event after initial gluten
challenge. The finding that small bowel secretions of patients
with isolated GSE have increased concentrations of myleo-
peroxidase, a neutrophil enzyme, when compared with
secretions from normal subjects, also supports a potential
role of neutrophils in the gastrointestinal pathology of
isolated GSE (Hallgren et al., 1989). It is possible that
neutrophils represent the earliest inflammatory cell but the
continued stimulation with gluten results in a transition to the
more typical mononuclear cell infiltrate. Recently, it has been
proposed that IL-6 may be an important cytokine in switching
the pattern of an inflammatory infiltrate from neutrophil
predominant pattern to the more mononuclear cell infiltrate
characteristic of chronic inflammation (Hurst et al., 2001;
Marin et al., 2001; Kaplanski et al., 2003). IL-6 has been
found to be a prominent cytokine produced in small bowel of
patients with gluten sensitivity (Przemioslo et al., 1994;
Kontakou et al., 1995). It is also important to note that none
of our patients with DH who had elevated serum IL-8 levels
and increased expression of IL-8 mRNA in the gut had
significant clinical gastrointestinal symptoms, while on a
gluten-containing diet despite having been diagnosed with
DH for an average of 12 years. In total, these observations
suggest that the local production of IL-8 may not be critical to
the symptomatic clinical gastrointestinal disease.
Although the elevated serum IL-8 levels do not appear to
play a primary role in the chronic gastrointestinal pathology,
persistent production of IL-8 may be important in the
development of the typical skin lesions seen in patients with
DH. Elevated serum levels of IL-8 have been found in the sera
of patients with a wide variety of inflammatory diseases
including polyarteritis nodosa, Behcet’s diseases, Wegner’s
granulomatosis, relapsing polychondritis, cutaneous T-cell
lymphoma, and post-streptococcal glomerulonephritis
(Besbas et al., 2004; de Lira Freire et al., 2004; Stabler
et al., 2004; Goddard et al., 2005; Torheim et al., 2005).
In addition, elevated levels of IL-8 have been found to be
associated with organ failure in patients with septic shock
(Takala et al., 1999). Many of these diseases are characteri-
zed by a significant neutrophilic infiltrate in the target organ,
as is present in the cutaneous infiltrate seen in patients with
DH. In animal model, antibodies directed against IL-8 have
been shown to regulate the inflammatory reaction in
inflammatory lung injury in rats, in joint inflammation
induced by IL-1a, and experimental glomerulonephritis
(Mulligan et al., 1993; Akahoshi et al., 1994; Wada et al.,
1994). These studies have clearly documented that local
production of IL-8 is critical for the development of
inflammatory lesions.
The role of elevated levels of serum IL-8 in the regulation
of inflammation however is less clear. Simonet reported that
transgenic mice that overexpressed IL-8 (serum concentra-
tions 1,000–106,000 pg/ml) exhibited an increase in neutro-
phils in the microcirculation without evidence of migration
into the tissue (Simonet et al., 1994). They also noted a
decreased neutrophil expression of L-selectin but no change
in CD11b expression in circulating neutrophils. Finally,
neutrophil migration into an inflamed peritoneal cavity was
inhibited in these transgenic animals (Simonet et al., 1994).
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In a similar manner, Hechtman et al. (1991) reported that
intravenous administration of IL-8 at a dosage of 1.2 mg/kg
could inhibit neutrophil-directed migration into skin that had
been injected with FMLP (N-formyl-methyonyl-leucyl-phenyl-
alanine), IL-1b, or C5a but that lower doses of IL-8 (0.12mg/kg)
did not inhibit neutrophil migration to a variety of
neutrophil chemoattractants. These findings suggest that
high concentrations of intravascular IL-8 may prevent
neutrophil adhesion to endothelial cells and suppress
inflammation, however, the levels of IL-8 expressed in the
animal studies are log orders higher than seen in our
patients.
In contrast, Schleiffenbaum has reported that the inhibition
of leukocyte emigration induced due to severe systemic
inflammation, such as occurs with sepsis, is not due to IL-8
(Schleiffenbaum et al., 1998). Remick et al. (2001) have also
reported that transgenic mice that express high plasma levels
of IL-8 (490 ng/ml) are able to mount a neutrophilic response
to inflammatory stimuli in gut, lung, and the peritoneum.
They demonstrated that neutrophils from mice with high
plasma IL-8 levels are able to show a chemotactic response to
IL-8 in vitro and that after local inflammatory stimulation, an
increase in local production of chemokines occurs leading to
neutrophil accumulation in tissue (Remick et al., 2001).
These studies suggest that local tissue inflammatory stimuli
are able to overcome increased IL-8 levels in the serum
through increased local production of IL-8 or other compen-
satory chemokines.
We have previously demonstrated that neutrophils in
patients with DH have an increased expression of CD11b and
slightly decreased cell surface L-selectin, consistent with
exposure to IL-8. In addition, we and others have demons-
trated that minor trauma to the skin can increase keratinocyte
expression of IL-8 and other cytokines (Strickland et al., 1997;
Takeuchi et al., 2003). It is possible that local production of
IL-8 may create a sufficient local concentration gradient of IL-
8 that would attract ‘‘partially primed neutrophils’’ to the
skin. Consistent with this hypothesis is the finding that
lesional skin of patients with DH had markedly increased
levels of IL-8 mRNA, greater than IL-8 mRNA expression in
the small bowel biopsies (DH patients on gluten diet: mean
IL-8 mRNA expression¼26.51 AU; DH lesional skin mean:
129.82 AU). This model would fit well with the clinical
observations that lesions of DH occur in extensor areas and in
areas of trauma to the skin (Koebner Phenomena).
Our studies however do not suggest that elevated serum
IL-8, even with changes in neutrophils that accompany such
elevations, is sufficient for the development of skin lesions.
The lack of skin lesions typical of DH in patients with isolated
GSE on gluten-containing diets, clearly demonstrates that
additional factors besides elevated serum IL-8 are needed for
the development of skin lesions. It is of interest to note that
transgenic mice that express IL-8 in the skin have been found
to have increased neutrophils in the skin at the dermal
epidermal junction but have no evidence of any pathologic
changes in the skin (Lira et al., 1994). In a similar manner,
transgenic mice that express IL-8 in the gut have been found
to have an increased neutrophilic infiltrate but no evidence of
mucosal damage (Kucharzik et al., 2005). These studies
suggest that additional factors are needed to trigger neutro-
phils and lead to the pathologic characteristics typical of skin
lesions of DH. The presence of IgA in the skin of patients with
DH and the presence of IgA receptors on the surface of
neutrophils suggest that IgA may function as an additional
proinflammatory stimulus.
In summary, we have demonstrated that patients with DH
with elevated serum levels of IL-8 show a normalization of
these levels with an associated reduction in the levels of
intestinal mucosal IL-8 mRNA expression and normalization
of serum IgA anti-TTG antibodies upon maintaining a GFD.
These findings are not seen in patients with DH that remain
on gluten-containing diets. Elevated serum IL-8 levels are also
found in the sera of patients with untreated isolated GSE.
These findings support the conclusion that the elevated serum
IL-8 is a consequence of the mucosal immune response to
gluten seen in patients with gluten sensitivity. We would
hypothesize that the development of skin lesions in DH is
dependent upon an ongoing mucosal immune response in
the gut associated with elevated IL-8 levels and ‘‘partial’’
priming or activation of neutrophils (Smith et al., 2002), the
local production of chemokines (perhaps as a result of local
trauma) (Takeuchi et al., 2003) sufficient to attract neutrophils
into the skin and finally the presence of IgA in the skin
allowing for the development of skin lesions. These findings
suggest that gastrointestinal inflammation may create a ‘‘pro-
inflammatory’’ profile in circulating inflammatory cells that
when accompanied by an otherwise minor elevation in local
cytokines may lead to development of significant local
inflammation. This may be an important mechanism in the
development of other skin disease associated with gastro-
intestinal inflammation and potentially other organs such as
the joints.
MATERIALS AND METHODS
Subjects
Seventeen patients with DH were studied. All patients had typical,
clinical, and histologic features of DH and granular deposits of IgA at
the dermal epidermal junction of normal appearing skin (nine male,
eight female, mean age¼ 50.2 year old range¼ 25–78 year old).
Ten of the DH patients were studied in order to evaluate the
relationship of gluten ingestion and serum IL-8 levels (six male, four
female, mean age¼ 44.3 years old range¼ 25–65 years old). These
DH patients had been diagnosed with DH for an average of 10.8
years (range 1–28 years) before the study. Nine of 10 patients were
on a normal containing diet at the time of initiation of the study,
whereas one patient had been on a GFD for 3 months at the time of
first evaluation. DH patients had a mean serum IL-8 level of
225.6 pg/ml (3.15–1,639 pg/ml; normalo4.91 pg/ml). Six patients
were begun or continued on a GFD (two male, four female, mean
age¼ 45 years old, mean duration of disease¼ 9.0 years), whereas
four continued on a normal diet (four male, mean age¼ 43.5, mean
duration of disease¼ 13.5 years). Patients were followed 0.5–5.5
years (mean 2.23 years). The choice of following a GFD or a regular
diet was based on the preference of the patient.
Small bowel biopsies were obtained by endoscopy from five
patients with DH on a regular gluten-containing diet and from two
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patients on a GFD. Small bowel biopsies were also obtained from six
subjects with no skin diseases undergoing small bowel biopsy for
evaluation of gastrointestinal complaints who did not have gluten
sensitivity and on small bowel biopsy had no evidence of isolated
GSE.
Punch biopsies of skin (4 mm) were obtained from six patients
with DH from normal inner arm skin during the period of no skin
lesions, on dapsone or sulfapyridine, from normal inner arm
skin during the period of active skin lesions off dapsone and from
skin lesions. Normal inner arm skin biopsies were obtained from eight
adult subjects with no history of skin disease (six female, two male).
Sera were obtained at the time of diagnostic small bowel biopsy
from 11 patients with isolated GSE on normal gluten-containing diets
(generously provided by Dr John Zone, University of Utah).
Complete demographic data are presented in Tables S1 and S2.
All studies were approved by the Duke University Health System
Institutional Review Board and consent was obtained from all
subjects. The study was conducted according to the Declaration of
Helsinki Principles.
Cytokine and IgA anti-tissue transglutaminase determination
Serum from DH patients, isolated GSE patients, and control subjects
was analyzed for 17 cytokines using the Bio-Plex microbead
cytokine assay (Bio-Rad Inc., Hercules, CA). Serum IL-8 levels in
one DH subject were determined by ELISA (Quantikine human IL-8,
R and D Systems, Minneapolis, MN). IgA anti-tissue transglutami-
nase antibody was determined using a commercially available ELISA
as directed by the manufacturer (Orgentec Diagnostika, Mainz,
Germany).
mRNA isolation of small bowel biopsies and skin biopsies
Total RNA was extracted from small bowel biopsies and skin
biopsies from patients, normal subjects and from peripheral blood
mononuclear cells using RNeasy mini kits (Qiagen, Valencia, CA).
To avoid contaminating DNA, Rnase-Free Dnase (Qiagen, Valencia,
CA) was utilized. The concentration of RNA was measured by a
spectrophotometer and stored at 821C in water. For cDNA
synthesis,B2mg total RNA was transcribed with cDNA transcription
reagents (Applied Biosystems, Foster City, CA) with the use of
random hexamers. Thermal cycler parameters included 10 minutes
at 251C for incubation, 30 minutes at 481C for reverse transcription-
reaction, and 5 minutes at 851C for enzyme inactivation. cDNA was
purified with PCR purification kits (Qiagen, Valencia, CA) and then
stored at 821C until quantitative real-time PCR was performed.
Real-time quantitative reverse transcription-PCR
Measurement of gene expression was performed utilizing the ABI
prism 7,700 Sequence Detection System (Applied Biosystems, Foster
City, CA) as described previously (Heid et al., 1996). TaqMan probes
were labeled at the 50-end with the reporter dye molecule FAM
(6-carboxyfluorescein; emission lmax¼ 518 nm) and at the 30-end with
the quencher dye molecule TAMRA (6-carboxytetramethylrhodami-
nef; emission lmax ¼ 582 nm). Reverse transcription-PCR reactions
of cDNA specimens and cDNA standards were conducted in a total
volume of 25 ml with 2 Taq Man Master Mix (Applied Biosystems,
Foster City, CA) and primers and probes at optimized concentrations.
Parameters for the thermal cycler were 2 minutes at 501C,
10 minutes at 951C, and 40 cycles involving denaturation at 951C
for 15 seconds, annealing/extension at 601C for 1 minute. Real-time
monitoring of fluorescent emission from cleavage of sequence-
specific probes by the nuclease activity of taq polymerase allowed
definition of the threshold cycle during the exponential phase of
amplification (Livak et al., 1995; Heid et al., 1996).
For analysis of IL-8 mRNA expression, a standard curve was
constructed with serial dilutions of cDNA obtained from single
sample of human peripheral blood mononuclear cells that had been
stimulated for 4 hours by PHA (phytohemagglutinin) (5 mg/ml). Cells
were removed and mRNA isolated and cDNA produced as described
above. Relative quantitation of IL-8 mRNA expression was deter-
mined using the relative standard curve method (User Bulletin no. 2
Applied Biosystems, Foster City, CA). Individual results were
normalized utilizing 18S ribosomal RNA as an internal control with
TaqMan ribosomal RNA control reagents (Applied Biosystems,
Foster City, CA). The IL-8 mRNA gene expression was normalized
to 18S ribosomal RNA expression of the cDNA preparation for all
subjects. All samples analyzed by real-time PCR were performed in
triplicate.
Design of IL-8 primers and probes
Oligonucleotide primers and TaqMan probes (demonstrated below)
were designed using PrimerQuest (Integrated DNA Technologies,
Coralville, IA). We conducted BLASTN searches to confirm the total
gene specificity of the nucleotide sequences chosen for primers and
probes and the absence of DNA polymorphism. To avoid
amplification of contaminating genomic DNA, one of the two
primers for cDNA was placed either at the junction between two
exons or within different exons. IL-8 primers were designed to result
in amplicons o150 bp to enhance efficiency of PCR amplification.
The following oligonucleotide primers and probe were used for real-
time reverse transcription-PCR for IL-8:
forward primer: 50-30
CTAAGTTCTTTAGCACTCCTTGGCA
reverse primer: 50-30
ATGACTTCCAAGCTGGCCG
probe: 50-30
FAM-ACAGAGCTGCAGAAATCAGGAAGGCTGCCA-3BHQ1
Statistical analysis
Results were analyzed using Mann–Whitney test and the Wilcoxon
Signed Ranks Test using Analyse-it for Microsoft Excel (ANALYSE-IT
SOFTWARE LTD PO Box 77, Leeds, LS12 5XA, England, UK).
Statistical significance was assumed for a P value p0.05.
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